The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global EGFR-TKI for Advanced NSCLC Market Research Report 2025
Synopsis
EGFR tyrosine kinase inhibitors (TKIs) are molecules that could inhibt EGFR function through binding. Its monotherapy as first-line treatment can benefit NSCLC patients harbouring EGFR mutations.
The global EGFR-TKI for Advanced NSCLC market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for EGFR-TKI for Advanced NSCLC is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for EGFR-TKI for Advanced NSCLC is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of EGFR-TKI for Advanced NSCLC include Henan DaKen Chemical, Capot Chemical Co.,Ltd., Chemwill Asia Co.,Ltd., MSN Labs, Sun Pharma, Amadis Chemical, Chongqing Chemdad Co., Ltd, Mylan and Alchem Pharmtech,Inc., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for EGFR-TKI for Advanced NSCLC, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding EGFR-TKI for Advanced NSCLC.
Report Scope
The EGFR-TKI for Advanced NSCLC market size, estimations, and forecasts are provided in terms of sales volume (Kilograms) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global EGFR-TKI for Advanced NSCLC market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the EGFR-TKI for Advanced NSCLC manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Henan DaKen Chemical
Capot Chemical Co.,Ltd.
Chemwill Asia Co.,Ltd.
MSN Labs
Sun Pharma
Amadis Chemical
Chongqing Chemdad Co., Ltd
Mylan
Alchem Pharmtech,Inc.
Segment by Type
Gefitinib
Erlotinib
Afatinib
Segment by Application
Combination Therapy
Mono Therapy
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of EGFR-TKI for Advanced NSCLC manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of EGFR-TKI for Advanced NSCLC in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
EGFR tyrosine kinase inhibitors (TKIs) are molecules that could inhibt EGFR function through binding. Its monotherapy as first-line treatment can benefit NSCLC patients harbouring EGFR mutations.
The global EGFR-TKI for Advanced NSCLC market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for EGFR-TKI for Advanced NSCLC is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for EGFR-TKI for Advanced NSCLC is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of EGFR-TKI for Advanced NSCLC include Henan DaKen Chemical, Capot Chemical Co.,Ltd., Chemwill Asia Co.,Ltd., MSN Labs, Sun Pharma, Amadis Chemical, Chongqing Chemdad Co., Ltd, Mylan and Alchem Pharmtech,Inc., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for EGFR-TKI for Advanced NSCLC, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding EGFR-TKI for Advanced NSCLC.
Report Scope
The EGFR-TKI for Advanced NSCLC market size, estimations, and forecasts are provided in terms of sales volume (Kilograms) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global EGFR-TKI for Advanced NSCLC market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the EGFR-TKI for Advanced NSCLC manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Henan DaKen Chemical
Capot Chemical Co.,Ltd.
Chemwill Asia Co.,Ltd.
MSN Labs
Sun Pharma
Amadis Chemical
Chongqing Chemdad Co., Ltd
Mylan
Alchem Pharmtech,Inc.
Segment by Type
Gefitinib
Erlotinib
Afatinib
Segment by Application
Combination Therapy
Mono Therapy
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of EGFR-TKI for Advanced NSCLC manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of EGFR-TKI for Advanced NSCLC in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 EGFR-TKI for Advanced NSCLC Market Overview
1.1 Product Overview and Scope of EGFR-TKI for Advanced NSCLC
1.2 EGFR-TKI for Advanced NSCLC Segment by Type
1.2.1 Global EGFR-TKI for Advanced NSCLC Market Value Comparison by Type (2024-2030)
1.2.2 Gefitinib
1.2.3 Erlotinib
1.2.4 Afatinib
1.3 EGFR-TKI for Advanced NSCLC Segment by Application
1.3.1 Global EGFR-TKI for Advanced NSCLC Market Value by Application: (2024-2030)
1.3.2 Combination Therapy
1.3.3 Mono Therapy
1.4 Global EGFR-TKI for Advanced NSCLC Market Size Estimates and Forecasts
1.4.1 Global EGFR-TKI for Advanced NSCLC Revenue 2019-2030
1.4.2 Global EGFR-TKI for Advanced NSCLC Sales 2019-2030
1.4.3 Global EGFR-TKI for Advanced NSCLC Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 EGFR-TKI for Advanced NSCLC Market Competition by Manufacturers
2.1 Global EGFR-TKI for Advanced NSCLC Sales Market Share by Manufacturers (2019-2024)
2.2 Global EGFR-TKI for Advanced NSCLC Revenue Market Share by Manufacturers (2019-2024)
2.3 Global EGFR-TKI for Advanced NSCLC Average Price by Manufacturers (2019-2024)
2.4 Global EGFR-TKI for Advanced NSCLC Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of EGFR-TKI for Advanced NSCLC, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of EGFR-TKI for Advanced NSCLC, Product Type & Application
2.7 EGFR-TKI for Advanced NSCLC Market Competitive Situation and Trends
2.7.1 EGFR-TKI for Advanced NSCLC Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest EGFR-TKI for Advanced NSCLC Players Market Share by Revenue
2.7.3 Global EGFR-TKI for Advanced NSCLC Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 EGFR-TKI for Advanced NSCLC Retrospective Market Scenario by Region
3.1 Global EGFR-TKI for Advanced NSCLC Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global EGFR-TKI for Advanced NSCLC Global EGFR-TKI for Advanced NSCLC Sales by Region: 2019-2030
3.2.1 Global EGFR-TKI for Advanced NSCLC Sales by Region: 2019-2024
3.2.2 Global EGFR-TKI for Advanced NSCLC Sales by Region: 2025-2030
3.3 Global EGFR-TKI for Advanced NSCLC Global EGFR-TKI for Advanced NSCLC Revenue by Region: 2019-2030
3.3.1 Global EGFR-TKI for Advanced NSCLC Revenue by Region: 2019-2024
3.3.2 Global EGFR-TKI for Advanced NSCLC Revenue by Region: 2025-2030
3.4 North America EGFR-TKI for Advanced NSCLC Market Facts & Figures by Country
3.4.1 North America EGFR-TKI for Advanced NSCLC Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America EGFR-TKI for Advanced NSCLC Sales by Country (2019-2030)
3.4.3 North America EGFR-TKI for Advanced NSCLC Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe EGFR-TKI for Advanced NSCLC Market Facts & Figures by Country
3.5.1 Europe EGFR-TKI for Advanced NSCLC Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe EGFR-TKI for Advanced NSCLC Sales by Country (2019-2030)
3.5.3 Europe EGFR-TKI for Advanced NSCLC Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific EGFR-TKI for Advanced NSCLC Market Facts & Figures by Country
3.6.1 Asia Pacific EGFR-TKI for Advanced NSCLC Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific EGFR-TKI for Advanced NSCLC Sales by Country (2019-2030)
3.6.3 Asia Pacific EGFR-TKI for Advanced NSCLC Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America EGFR-TKI for Advanced NSCLC Market Facts & Figures by Country
3.7.1 Latin America EGFR-TKI for Advanced NSCLC Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America EGFR-TKI for Advanced NSCLC Sales by Country (2019-2030)
3.7.3 Latin America EGFR-TKI for Advanced NSCLC Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa EGFR-TKI for Advanced NSCLC Market Facts & Figures by Country
3.8.1 Middle East and Africa EGFR-TKI for Advanced NSCLC Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa EGFR-TKI for Advanced NSCLC Sales by Country (2019-2030)
3.8.3 Middle East and Africa EGFR-TKI for Advanced NSCLC Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global EGFR-TKI for Advanced NSCLC Sales by Type (2019-2030)
4.1.1 Global EGFR-TKI for Advanced NSCLC Sales by Type (2019-2024)
4.1.2 Global EGFR-TKI for Advanced NSCLC Sales by Type (2025-2030)
4.1.3 Global EGFR-TKI for Advanced NSCLC Sales Market Share by Type (2019-2030)
4.2 Global EGFR-TKI for Advanced NSCLC Revenue by Type (2019-2030)
4.2.1 Global EGFR-TKI for Advanced NSCLC Revenue by Type (2019-2024)
4.2.2 Global EGFR-TKI for Advanced NSCLC Revenue by Type (2025-2030)
4.2.3 Global EGFR-TKI for Advanced NSCLC Revenue Market Share by Type (2019-2030)
4.3 Global EGFR-TKI for Advanced NSCLC Price by Type (2019-2030)
5 Segment by Application
5.1 Global EGFR-TKI for Advanced NSCLC Sales by Application (2019-2030)
5.1.1 Global EGFR-TKI for Advanced NSCLC Sales by Application (2019-2024)
5.1.2 Global EGFR-TKI for Advanced NSCLC Sales by Application (2025-2030)
5.1.3 Global EGFR-TKI for Advanced NSCLC Sales Market Share by Application (2019-2030)
5.2 Global EGFR-TKI for Advanced NSCLC Revenue by Application (2019-2030)
5.2.1 Global EGFR-TKI for Advanced NSCLC Revenue by Application (2019-2024)
5.2.2 Global EGFR-TKI for Advanced NSCLC Revenue by Application (2025-2030)
5.2.3 Global EGFR-TKI for Advanced NSCLC Revenue Market Share by Application (2019-2030)
5.3 Global EGFR-TKI for Advanced NSCLC Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Henan DaKen Chemical
6.1.1 Henan DaKen Chemical Corporation Information
6.1.2 Henan DaKen Chemical Description and Business Overview
6.1.3 Henan DaKen Chemical EGFR-TKI for Advanced NSCLC Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Henan DaKen Chemical EGFR-TKI for Advanced NSCLC Product Portfolio
6.1.5 Henan DaKen Chemical Recent Developments/Updates
6.2 Capot Chemical Co.,Ltd.
6.2.1 Capot Chemical Co.,Ltd. Corporation Information
6.2.2 Capot Chemical Co.,Ltd. Description and Business Overview
6.2.3 Capot Chemical Co.,Ltd. EGFR-TKI for Advanced NSCLC Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Capot Chemical Co.,Ltd. EGFR-TKI for Advanced NSCLC Product Portfolio
6.2.5 Capot Chemical Co.,Ltd. Recent Developments/Updates
6.3 Chemwill Asia Co.,Ltd.
6.3.1 Chemwill Asia Co.,Ltd. Corporation Information
6.3.2 Chemwill Asia Co.,Ltd. Description and Business Overview
6.3.3 Chemwill Asia Co.,Ltd. EGFR-TKI for Advanced NSCLC Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Chemwill Asia Co.,Ltd. EGFR-TKI for Advanced NSCLC Product Portfolio
6.3.5 Chemwill Asia Co.,Ltd. Recent Developments/Updates
6.4 MSN Labs
6.4.1 MSN Labs Corporation Information
6.4.2 MSN Labs Description and Business Overview
6.4.3 MSN Labs EGFR-TKI for Advanced NSCLC Sales, Revenue and Gross Margin (2019-2024)
6.4.4 MSN Labs EGFR-TKI for Advanced NSCLC Product Portfolio
6.4.5 MSN Labs Recent Developments/Updates
6.5 Sun Pharma
6.5.1 Sun Pharma Corporation Information
6.5.2 Sun Pharma Description and Business Overview
6.5.3 Sun Pharma EGFR-TKI for Advanced NSCLC Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Sun Pharma EGFR-TKI for Advanced NSCLC Product Portfolio
6.5.5 Sun Pharma Recent Developments/Updates
6.6 Amadis Chemical
6.6.1 Amadis Chemical Corporation Information
6.6.2 Amadis Chemical Description and Business Overview
6.6.3 Amadis Chemical EGFR-TKI for Advanced NSCLC Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Amadis Chemical EGFR-TKI for Advanced NSCLC Product Portfolio
6.6.5 Amadis Chemical Recent Developments/Updates
6.7 Chongqing Chemdad Co., Ltd
6.6.1 Chongqing Chemdad Co., Ltd Corporation Information
6.6.2 Chongqing Chemdad Co., Ltd Description and Business Overview
6.6.3 Chongqing Chemdad Co., Ltd EGFR-TKI for Advanced NSCLC Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Chongqing Chemdad Co., Ltd EGFR-TKI for Advanced NSCLC Product Portfolio
6.7.5 Chongqing Chemdad Co., Ltd Recent Developments/Updates
6.8 Mylan
6.8.1 Mylan Corporation Information
6.8.2 Mylan Description and Business Overview
6.8.3 Mylan EGFR-TKI for Advanced NSCLC Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Mylan EGFR-TKI for Advanced NSCLC Product Portfolio
6.8.5 Mylan Recent Developments/Updates
6.9 Alchem Pharmtech,Inc.
6.9.1 Alchem Pharmtech,Inc. Corporation Information
6.9.2 Alchem Pharmtech,Inc. Description and Business Overview
6.9.3 Alchem Pharmtech,Inc. EGFR-TKI for Advanced NSCLC Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Alchem Pharmtech,Inc. EGFR-TKI for Advanced NSCLC Product Portfolio
6.9.5 Alchem Pharmtech,Inc. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 EGFR-TKI for Advanced NSCLC Industry Chain Analysis
7.2 EGFR-TKI for Advanced NSCLC Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 EGFR-TKI for Advanced NSCLC Production Mode & Process
7.4 EGFR-TKI for Advanced NSCLC Sales and Marketing
7.4.1 EGFR-TKI for Advanced NSCLC Sales Channels
7.4.2 EGFR-TKI for Advanced NSCLC Distributors
7.5 EGFR-TKI for Advanced NSCLC Customers
8 EGFR-TKI for Advanced NSCLC Market Dynamics
8.1 EGFR-TKI for Advanced NSCLC Industry Trends
8.2 EGFR-TKI for Advanced NSCLC Market Drivers
8.3 EGFR-TKI for Advanced NSCLC Market Challenges
8.4 EGFR-TKI for Advanced NSCLC Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global EGFR-TKI for Advanced NSCLC Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global EGFR-TKI for Advanced NSCLC Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global EGFR-TKI for Advanced NSCLC Market Competitive Situation by Manufacturers in 2023
Table 4. Global EGFR-TKI for Advanced NSCLC Sales (Kilograms) of Key Manufacturers (2019-2024)
Table 5. Global EGFR-TKI for Advanced NSCLC Sales Market Share by Manufacturers (2019-2024)
Table 6. Global EGFR-TKI for Advanced NSCLC Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global EGFR-TKI for Advanced NSCLC Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market EGFR-TKI for Advanced NSCLC Average Price (US$/Gram) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of EGFR-TKI for Advanced NSCLC, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of EGFR-TKI for Advanced NSCLC, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of EGFR-TKI for Advanced NSCLC, Product Type & Application
Table 12. Global Key Manufacturers of EGFR-TKI for Advanced NSCLC, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global EGFR-TKI for Advanced NSCLC by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in EGFR-TKI for Advanced NSCLC as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global EGFR-TKI for Advanced NSCLC Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global EGFR-TKI for Advanced NSCLC Sales by Region (2019-2024) & (Kilograms)
Table 18. Global EGFR-TKI for Advanced NSCLC Sales Market Share by Region (2019-2024)
Table 19. Global EGFR-TKI for Advanced NSCLC Sales by Region (2025-2030) & (Kilograms)
Table 20. Global EGFR-TKI for Advanced NSCLC Sales Market Share by Region (2025-2030)
Table 21. Global EGFR-TKI for Advanced NSCLC Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global EGFR-TKI for Advanced NSCLC Revenue Market Share by Region (2019-2024)
Table 23. Global EGFR-TKI for Advanced NSCLC Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global EGFR-TKI for Advanced NSCLC Revenue Market Share by Region (2025-2030)
Table 25. North America EGFR-TKI for Advanced NSCLC Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America EGFR-TKI for Advanced NSCLC Sales by Country (2019-2024) & (Kilograms)
Table 27. North America EGFR-TKI for Advanced NSCLC Sales by Country (2025-2030) & (Kilograms)
Table 28. North America EGFR-TKI for Advanced NSCLC Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America EGFR-TKI for Advanced NSCLC Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe EGFR-TKI for Advanced NSCLC Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe EGFR-TKI for Advanced NSCLC Sales by Country (2019-2024) & (Kilograms)
Table 32. Europe EGFR-TKI for Advanced NSCLC Sales by Country (2025-2030) & (Kilograms)
Table 33. Europe EGFR-TKI for Advanced NSCLC Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe EGFR-TKI for Advanced NSCLC Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific EGFR-TKI for Advanced NSCLC Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific EGFR-TKI for Advanced NSCLC Sales by Region (2019-2024) & (Kilograms)
Table 37. Asia Pacific EGFR-TKI for Advanced NSCLC Sales by Region (2025-2030) & (Kilograms)
Table 38. Asia Pacific EGFR-TKI for Advanced NSCLC Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific EGFR-TKI for Advanced NSCLC Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America EGFR-TKI for Advanced NSCLC Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America EGFR-TKI for Advanced NSCLC Sales by Country (2019-2024) & (Kilograms)
Table 42. Latin America EGFR-TKI for Advanced NSCLC Sales by Country (2025-2030) & (Kilograms)
Table 43. Latin America EGFR-TKI for Advanced NSCLC Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America EGFR-TKI for Advanced NSCLC Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa EGFR-TKI for Advanced NSCLC Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa EGFR-TKI for Advanced NSCLC Sales by Country (2019-2024) & (Kilograms)
Table 47. Middle East & Africa EGFR-TKI for Advanced NSCLC Sales by Country (2025-2030) & (Kilograms)
Table 48. Middle East & Africa EGFR-TKI for Advanced NSCLC Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa EGFR-TKI for Advanced NSCLC Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global EGFR-TKI for Advanced NSCLC Sales (Kilograms) by Type (2019-2024)
Table 51. Global EGFR-TKI for Advanced NSCLC Sales (Kilograms) by Type (2025-2030)
Table 52. Global EGFR-TKI for Advanced NSCLC Sales Market Share by Type (2019-2024)
Table 53. Global EGFR-TKI for Advanced NSCLC Sales Market Share by Type (2025-2030)
Table 54. Global EGFR-TKI for Advanced NSCLC Revenue (US$ Million) by Type (2019-2024)
Table 55. Global EGFR-TKI for Advanced NSCLC Revenue (US$ Million) by Type (2025-2030)
Table 56. Global EGFR-TKI for Advanced NSCLC Revenue Market Share by Type (2019-2024)
Table 57. Global EGFR-TKI for Advanced NSCLC Revenue Market Share by Type (2025-2030)
Table 58. Global EGFR-TKI for Advanced NSCLC Price (US$/Gram) by Type (2019-2024)
Table 59. Global EGFR-TKI for Advanced NSCLC Price (US$/Gram) by Type (2025-2030)
Table 60. Global EGFR-TKI for Advanced NSCLC Sales (Kilograms) by Application (2019-2024)
Table 61. Global EGFR-TKI for Advanced NSCLC Sales (Kilograms) by Application (2025-2030)
Table 62. Global EGFR-TKI for Advanced NSCLC Sales Market Share by Application (2019-2024)
Table 63. Global EGFR-TKI for Advanced NSCLC Sales Market Share by Application (2025-2030)
Table 64. Global EGFR-TKI for Advanced NSCLC Revenue (US$ Million) by Application (2019-2024)
Table 65. Global EGFR-TKI for Advanced NSCLC Revenue (US$ Million) by Application (2025-2030)
Table 66. Global EGFR-TKI for Advanced NSCLC Revenue Market Share by Application (2019-2024)
Table 67. Global EGFR-TKI for Advanced NSCLC Revenue Market Share by Application (2025-2030)
Table 68. Global EGFR-TKI for Advanced NSCLC Price (US$/Gram) by Application (2019-2024)
Table 69. Global EGFR-TKI for Advanced NSCLC Price (US$/Gram) by Application (2025-2030)
Table 70. Henan DaKen Chemical Corporation Information
Table 71. Henan DaKen Chemical Description and Business Overview
Table 72. Henan DaKen Chemical EGFR-TKI for Advanced NSCLC Sales (Kilograms), Revenue (US$ Million), Price (US$/Gram) and Gross Margin (2019-2024)
Table 73. Henan DaKen Chemical EGFR-TKI for Advanced NSCLC Product
Table 74. Henan DaKen Chemical Recent Developments/Updates
Table 75. Capot Chemical Co.,Ltd. Corporation Information
Table 76. Capot Chemical Co.,Ltd. Description and Business Overview
Table 77. Capot Chemical Co.,Ltd. EGFR-TKI for Advanced NSCLC Sales (Kilograms), Revenue (US$ Million), Price (US$/Gram) and Gross Margin (2019-2024)
Table 78. Capot Chemical Co.,Ltd. EGFR-TKI for Advanced NSCLC Product
Table 79. Capot Chemical Co.,Ltd. Recent Developments/Updates
Table 80. Chemwill Asia Co.,Ltd. Corporation Information
Table 81. Chemwill Asia Co.,Ltd. Description and Business Overview
Table 82. Chemwill Asia Co.,Ltd. EGFR-TKI for Advanced NSCLC Sales (Kilograms), Revenue (US$ Million), Price (US$/Gram) and Gross Margin (2019-2024)
Table 83. Chemwill Asia Co.,Ltd. EGFR-TKI for Advanced NSCLC Product
Table 84. Chemwill Asia Co.,Ltd. Recent Developments/Updates
Table 85. MSN Labs Corporation Information
Table 86. MSN Labs Description and Business Overview
Table 87. MSN Labs EGFR-TKI for Advanced NSCLC Sales (Kilograms), Revenue (US$ Million), Price (US$/Gram) and Gross Margin (2019-2024)
Table 88. MSN Labs EGFR-TKI for Advanced NSCLC Product
Table 89. MSN Labs Recent Developments/Updates
Table 90. Sun Pharma Corporation Information
Table 91. Sun Pharma Description and Business Overview
Table 92. Sun Pharma EGFR-TKI for Advanced NSCLC Sales (Kilograms), Revenue (US$ Million), Price (US$/Gram) and Gross Margin (2019-2024)
Table 93. Sun Pharma EGFR-TKI for Advanced NSCLC Product
Table 94. Sun Pharma Recent Developments/Updates
Table 95. Amadis Chemical Corporation Information
Table 96. Amadis Chemical Description and Business Overview
Table 97. Amadis Chemical EGFR-TKI for Advanced NSCLC Sales (Kilograms), Revenue (US$ Million), Price (US$/Gram) and Gross Margin (2019-2024)
Table 98. Amadis Chemical EGFR-TKI for Advanced NSCLC Product
Table 99. Amadis Chemical Recent Developments/Updates
Table 100. Chongqing Chemdad Co., Ltd Corporation Information
Table 101. Chongqing Chemdad Co., Ltd Description and Business Overview
Table 102. Chongqing Chemdad Co., Ltd EGFR-TKI for Advanced NSCLC Sales (Kilograms), Revenue (US$ Million), Price (US$/Gram) and Gross Margin (2019-2024)
Table 103. Chongqing Chemdad Co., Ltd EGFR-TKI for Advanced NSCLC Product
Table 104. Chongqing Chemdad Co., Ltd Recent Developments/Updates
Table 105. Mylan Corporation Information
Table 106. Mylan Description and Business Overview
Table 107. Mylan EGFR-TKI for Advanced NSCLC Sales (Kilograms), Revenue (US$ Million), Price (US$/Gram) and Gross Margin (2019-2024)
Table 108. Mylan EGFR-TKI for Advanced NSCLC Product
Table 109. Mylan Recent Developments/Updates
Table 110. Alchem Pharmtech,Inc. Corporation Information
Table 111. Alchem Pharmtech,Inc. Description and Business Overview
Table 112. Alchem Pharmtech,Inc. EGFR-TKI for Advanced NSCLC Sales (Kilograms), Revenue (US$ Million), Price (US$/Gram) and Gross Margin (2019-2024)
Table 113. Alchem Pharmtech,Inc. EGFR-TKI for Advanced NSCLC Product
Table 114. Alchem Pharmtech,Inc. Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. EGFR-TKI for Advanced NSCLC Distributors List
Table 118. EGFR-TKI for Advanced NSCLC Customers List
Table 119. EGFR-TKI for Advanced NSCLC Market Trends
Table 120. EGFR-TKI for Advanced NSCLC Market Drivers
Table 121. EGFR-TKI for Advanced NSCLC Market Challenges
Table 122. EGFR-TKI for Advanced NSCLC Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of EGFR-TKI for Advanced NSCLC
Figure 2. Global EGFR-TKI for Advanced NSCLC Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global EGFR-TKI for Advanced NSCLC Market Share by Type in 2023 & 2030
Figure 4. Gefitinib Product Picture
Figure 5. Erlotinib Product Picture
Figure 6. Afatinib Product Picture
Figure 7. Global EGFR-TKI for Advanced NSCLC Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global EGFR-TKI for Advanced NSCLC Market Share by Application in 2023 & 2030
Figure 9. Combination Therapy
Figure 10. Mono Therapy
Figure 11. Global EGFR-TKI for Advanced NSCLC Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global EGFR-TKI for Advanced NSCLC Market Size (2019-2030) & (US$ Million)
Figure 13. Global EGFR-TKI for Advanced NSCLC Sales (2019-2030) & (Kilograms)
Figure 14. Global EGFR-TKI for Advanced NSCLC Average Price (US$/Gram) & (2019-2030)
Figure 15. EGFR-TKI for Advanced NSCLC Report Years Considered
Figure 16. EGFR-TKI for Advanced NSCLC Sales Share by Manufacturers in 2023
Figure 17. Global EGFR-TKI for Advanced NSCLC Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest EGFR-TKI for Advanced NSCLC Players: Market Share by Revenue in 2023
Figure 19. EGFR-TKI for Advanced NSCLC Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global EGFR-TKI for Advanced NSCLC Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America EGFR-TKI for Advanced NSCLC Sales Market Share by Country (2019-2030)
Figure 22. North America EGFR-TKI for Advanced NSCLC Revenue Market Share by Country (2019-2030)
Figure 23. U.S. EGFR-TKI for Advanced NSCLC Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada EGFR-TKI for Advanced NSCLC Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe EGFR-TKI for Advanced NSCLC Sales Market Share by Country (2019-2030)
Figure 26. Europe EGFR-TKI for Advanced NSCLC Revenue Market Share by Country (2019-2030)
Figure 27. Germany EGFR-TKI for Advanced NSCLC Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France EGFR-TKI for Advanced NSCLC Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. EGFR-TKI for Advanced NSCLC Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy EGFR-TKI for Advanced NSCLC Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia EGFR-TKI for Advanced NSCLC Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific EGFR-TKI for Advanced NSCLC Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific EGFR-TKI for Advanced NSCLC Revenue Market Share by Region (2019-2030)
Figure 34. China EGFR-TKI for Advanced NSCLC Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan EGFR-TKI for Advanced NSCLC Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea EGFR-TKI for Advanced NSCLC Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India EGFR-TKI for Advanced NSCLC Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia EGFR-TKI for Advanced NSCLC Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Taiwan EGFR-TKI for Advanced NSCLC Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia EGFR-TKI for Advanced NSCLC Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand EGFR-TKI for Advanced NSCLC Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia EGFR-TKI for Advanced NSCLC Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Philippines EGFR-TKI for Advanced NSCLC Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America EGFR-TKI for Advanced NSCLC Sales Market Share by Country (2019-2030)
Figure 45. Latin America EGFR-TKI for Advanced NSCLC Revenue Market Share by Country (2019-2030)
Figure 46. Mexico EGFR-TKI for Advanced NSCLC Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil EGFR-TKI for Advanced NSCLC Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina EGFR-TKI for Advanced NSCLC Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa EGFR-TKI for Advanced NSCLC Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa EGFR-TKI for Advanced NSCLC Revenue Market Share by Country (2019-2030)
Figure 51. Turkey EGFR-TKI for Advanced NSCLC Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia EGFR-TKI for Advanced NSCLC Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. UAE EGFR-TKI for Advanced NSCLC Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of EGFR-TKI for Advanced NSCLC by Type (2019-2030)
Figure 55. Global Revenue Market Share of EGFR-TKI for Advanced NSCLC by Type (2019-2030)
Figure 56. Global EGFR-TKI for Advanced NSCLC Price (US$/Gram) by Type (2019-2030)
Figure 57. Global Sales Market Share of EGFR-TKI for Advanced NSCLC by Application (2019-2030)
Figure 58. Global Revenue Market Share of EGFR-TKI for Advanced NSCLC by Application (2019-2030)
Figure 59. Global EGFR-TKI for Advanced NSCLC Price (US$/Gram) by Application (2019-2030)
Figure 60. EGFR-TKI for Advanced NSCLC Value Chain
Figure 61. EGFR-TKI for Advanced NSCLC Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
